Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Exelixis Inc (NASDAQ: EXEL) closed the day trading at $32.88 down -9.74% from the previous closing price of $36.43. In other words, the price has decreased by -$9.74 from its previous closing price. On the day, 3.83 million shares were traded. EXEL stock price reached its highest trading level at $36.56 during the session, while it also had its lowest trading level at $32.7301.
Ratios:
For a better understanding of EXEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.70. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.93. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BMO Capital Markets on December 20, 2024, Downgraded its rating to Market Perform and sets its target price to $40 from $36 previously.
On December 17, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $35 to $39.
RBC Capital Mkts reiterated its Outperform rating for the stock on October 16, 2024, while the target price for the stock was revised from $30 to $34.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 29 ’24 when Hessekiel Jeffrey sold 60,000 shares for $36.67 per share. The transaction valued at 2,200,200 led to the insider holds 486,059 shares of the business.
JEFFREY HESSEKIEL bought 60,000 shares of EXEL for $2,200,230 on Nov 29 ’24. On Nov 22 ’24, another insider, Haley Patrick J., who serves as the EVP, Commercial of the company, sold 10,000 shares for $35.27 each. As a result, the insider received 352,700 and left with 278,665 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 9389838336 and an Enterprise Value of 8395122176. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.95, and their Forward P/E ratio for the next fiscal year is 17.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.51 while its Price-to-Book (P/B) ratio in mrq is 4.13. Its current Enterprise Value per Revenue stands at 4.033 whereas that against EBITDA is 13.201.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.54, which has changed by 0.48845637 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $37.59, while it has fallen to a 52-week low of $20.01. The 50-Day Moving Average of the stock is -6.17%, while the 200-Day Moving Average is calculated to be 21.18%.
Shares Statistics:
Over the past 3-months, EXEL traded about 2.27M shares per day on average, while over the past 10 days, EXEL traded about 2993070 shares per day. A total of 285.78M shares are outstanding, with a floating share count of 277.78M. Insiders hold about 2.73% of the company’s shares, while institutions hold 87.78% stake in the company. Shares short for EXEL as of 1735603200 were 10450134 with a Short Ratio of 4.61, compared to 1732838400 on 8357534. Therefore, it implies a Short% of Shares Outstanding of 10450134 and a Short% of Float of 4.9200002.
Earnings Estimates
The dynamic stock of Exelixis Inc (EXEL) is currently being evaluated by a team of 14.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.41, with high estimates of $0.63 and low estimates of $0.25.
Analysts are recommending an EPS of between $2.22 and $1.72 for the fiscal current year, implying an average EPS of $1.96. EPS for the following year is $2.1, with 14.0 analysts recommending between $2.53 and $1.6.
Revenue Estimates
18 analysts predict $559.61M in revenue for the current quarter. It ranges from a high estimate of $579M to a low estimate of $502.62M. As of the current estimate, Exelixis Inc’s year-ago sales were $479.65MFor the next quarter, 18 analysts are estimating revenue of $506.03M. There is a high estimate of $568.5M for the next quarter, whereas the lowest estimate is $450M.
A total of 22 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $2.2B, while the lowest revenue estimate was $2.06B, resulting in an average revenue estimate of $2.16B. In the same quarter a year ago, actual revenue was $1.83BBased on 20 analysts’ estimates, the company’s revenue will be $2.23B in the next fiscal year. The high estimate is $2.44B and the low estimate is $2.04B.
